Instil Bio annual r&d spending
2020
2021
2022
2023
2024
2025
Instil Bio R&D Spending Growth & History (TIL)
Instil Bio's r&d spending was $24.7M for fiscal 2025.
View full Instil Bio company overviewInstil Bio annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $24.7M | $12.9M | +108.97% |
| 2024 | 2024-12-31 | $11.8M | −$27.8M | −70.11% |
| 2023 | 2023-12-31 | $39.6M | −$101.5M | −71.92% |
| 2022 | 2022-12-31 | $141.1M | $33.8M | +31.52% |
| 2021 | 2021-12-31 | $107.3M | $87.9M | +452.87% |
| 2020 | 2020-12-31 | $19.4M | — | — |
Instil Bio quarterly r&d spending
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $270,000 | −$6.5M | −96.00% |
| Q1 2026 | 2026-03-31 | $669,000 | −$4.7M | −87.54% |
| Q4 2025 | 2025-12-31 | $3.5M | $2.4M | +218.20% |
| Q3 2025 | 2025-09-30 | $9.1M | $8.6M | +1524.02% |
| Q2 2025 | 2025-06-30 | $6.7M | $3.8M | +130.85% |
| Q1 2025 | 2025-03-31 | $5.4M | −$1.9M | −25.98% |
| Q4 2024 | 2024-12-31 | $1.1M | −$884,000 | −44.58% |
| Q3 2024 | 2024-09-30 | $562,000 | −$7.9M | −93.38% |
| Q2 2024 | 2024-06-30 | $2.9M | −$5.5M | −65.47% |
| Q1 2024 | 2024-03-31 | $7.3M | −$13.4M | −64.90% |
| Q4 2023 | 2023-12-31 | $2.0M | −$18.7M | −90.43% |
| Q3 2023 | 2023-09-30 | $8.5M | −$31.2M | −78.59% |
| Q2 2023 | 2023-06-30 | $8.5M | −$33.0M | −79.62% |
| Q1 2023 | 2023-03-31 | $20.7M | −$18.5M | −47.24% |
| Q4 2022 | 2022-12-31 | $20.7M | −$21.9M | −51.33% |
| Q3 2022 | 2022-09-30 | $39.7M | $10.6M | +36.46% |
| Q2 2022 | 2022-06-30 | $41.5M | $20.3M | +95.88% |
| Q1 2022 | 2022-03-31 | $39.2M | $24.8M | +171.59% |
| Q4 2021 | 2021-12-31 | $42.6M | $32.3M | +315.51% |
| Q3 2021 | 2021-09-30 | $29.1M | $24.2M | +492.18% |
| Q2 2021 | 2021-06-30 | $21.2M | $18.9M | +847.07% |
| Q1 2021 | 2021-03-31 | $14.4M | $12.4M | +618.68% |
| Q4 2020 | 2020-12-31 | $10.2M | — | — |
| Q3 2020 | 2020-09-30 | $4.9M | — | — |
| Q2 2020 | 2020-06-30 | $2.2M | — | — |
| Q1 2020 | 2020-03-31 | $2.0M | — | — |
Instil Bio r&d spending trends
Over the last five fiscal years, Instil Bio's r&d spending increased from $19.4M to $24.7M, a change of $5.3M. The latest reported quarter, Q2 2026, shows $270,000.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Instil Bio source filings ↗